<DOC>
	<DOCNO>NCT03060057</DOCNO>
	<brief_summary>The purpose study evaluate short long term clinical performance safety commercially available U2 Knee™ System .</brief_summary>
	<brief_title>Prospective Post Approval Clinical Follow-Up Study Commercially Available U2 Knee™ System - `` U-Propel Study ''</brief_title>
	<detailed_description>This prospective , single arm , multi-center , post-approval study design evaluate short long term clinical performance safety subject receive primary total knee arthroplasty ( TKA ) U2 Knee™ System . The study enroll 200 subject schedule pre-discharge , 6-week , 3- 6-month 5-year annual follow-up visit . Study outcomes analyze publish 1 . ) enrol implanted subject complete 6-week follow , 2 . ) implant subject complete 2-year follow , 3 . ) conclusion study . The study follow GCP guideline register clinicaltrials.gov .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>1 . Subject 18 75 year age 2 . Subject indicated unilateral total knee arthroplasty ( TKA ) base approve labeling device 3 . Subject history previous prosthetic replacement device orthopedic surgery operative knee 4 . Subject willing able provide inform consent participate study ; 5 . Subject willing able understand purpose study , his/her role , available return clinic/hospital require followup visit ; Subjects exclude , opinion Investigator , subject qualify base approve labeling requirement Subject Inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>